GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced that Christopher A. McGinnis has been appointed as Chief Financial Officer, effective February 4, 2025.

GoodRx Holdings Inc. (NASDAQ:GDRX), a leading healthcare technology company specializing in prescription drug discounts and ...

We recently compiled a list of the 10 Best Affordable Stocks Under $5 to Buy Now. In this article, we are going to take a ...

GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $4.95, but opened at $4.81. GoodRx shares last traded at ...

In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on GoodRx Holdings (GDRX – Research Report), with a price ...

SANTA MONICA, Calif., January 30, 2025--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its ...

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will relea ...

GDRX returned to sequential growth in subscribers in Q3, showing potential for profit improvement and a near-term bottom. Adjusted EBITDA margins also continued to improve after the company's ...

A number of institutional investors have recently added to or reduced their stakes in GDRX. Fortem Financial Group LLC boosted its stake in shares of GoodRx by 7.2% during the 4th quarter. Fortem ...

View GoodRx Holdings, Inc. (GDRX) current and estimated P/E ratio data provided by Seeking Alpha.